EDGAR Filing Documents for 0001169245-23-000056

Form 8-K - Current report:

SEC Accession No. 0001169245-23-000056

Filing Date

2023-11-29

Accepted

2023-11-29 16:55:08

Documents

Period of Report

2023-11-17

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	phas-20231117.htm iXBRL	8-K	36807
2	EX-99.1	phasqmorsep2023.htm	EX-99.1	31699
3	EX-99.2	phasqmoroct2023.htm	EX-99.2	29641
7		phasqmoroct2023001.jpg	GRAPHIC	141803
8		phasqmoroct2023002.jpg	GRAPHIC	189189
9		phasqmoroct2023003.jpg	GRAPHIC	174381
10		phasqmoroct2023004.jpg	GRAPHIC	142466
11		phasqmoroct2023005.jpg	GRAPHIC	150456
12		phasqmoroct2023006.jpg	GRAPHIC	141987
13		phasqmoroct2023007.jpg	GRAPHIC	143207
14		phasqmoroct2023008.jpg	GRAPHIC	164424
15		phasqmoroct2023009.jpg	GRAPHIC	203834
16		phasqmoroct2023010.jpg	GRAPHIC	355260
17		phasqmoroct2023011.jpg	GRAPHIC	344523
18		phasqmoroct2023012.jpg	GRAPHIC	199811
19		phasqmoroct2023013.jpg	GRAPHIC	201353
20		phasqmoroct2023014.jpg	GRAPHIC	214731
21		phasqmoroct2023015.jpg	GRAPHIC	80721
22		phasqmoroct2023016.jpg	GRAPHIC	62361
23		phasqmoroct2023017.jpg	GRAPHIC	87250
24		phasqmoroct2023018.jpg	GRAPHIC	69301
25		phasqmoroct2023019.jpg	GRAPHIC	69318
26		phasqmorsep2023001.jpg	GRAPHIC	141829
27		phasqmorsep2023002.jpg	GRAPHIC	189400
28		phasqmorsep2023003.jpg	GRAPHIC	176048
29		phasqmorsep2023004.jpg	GRAPHIC	142450
30		phasqmorsep2023005.jpg	GRAPHIC	150431
31		phasqmorsep2023006.jpg	GRAPHIC	141809
32		phasqmorsep2023007.jpg	GRAPHIC	143338
33		phasqmorsep2023008.jpg	GRAPHIC	164487
34		phasqmorsep2023009.jpg	GRAPHIC	203723
35		phasqmorsep2023010.jpg	GRAPHIC	353890
36		phasqmorsep2023011.jpg	GRAPHIC	348135
37		phasqmorsep2023012.jpg	GRAPHIC	199909
38		phasqmorsep2023013.jpg	GRAPHIC	208788
39		phasqmorsep2023014.jpg	GRAPHIC	277452
40		phasqmorsep2023015.jpg	GRAPHIC	39671
41		phasqmorsep2023016.jpg	GRAPHIC	51289
42		phasqmorsep2023017.jpg	GRAPHIC	81921
43		phasqmorsep2023018.jpg	GRAPHIC	63385
44		phasqmorsep2023019.jpg	GRAPHIC	87617
45		phasqmorsep2023020.jpg	GRAPHIC	69712
46		phasqmorsep2023021.jpg	GRAPHIC	69680
	Complete submission text file	0001169245-23-000056.txt		9126277

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	phas-20231117.xsd	EX-101.SCH	1904
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	phas-20231117_lab.xml	EX-101.LAB	25850
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	phas-20231117_pre.xml	EX-101.PRE	13583
48	EXTRACTED XBRL INSTANCE DOCUMENT	phas-20231117_htm.xml	XML	2818

Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355

Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500

PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)